N/A N=39 Randomized Single-blind Prevention

A Multidomain Approach to Preventing Dementia in African Americans: Cognitive Prescriptions

Cognitive Change · Health Behavior · Health Literacy

Bottom Line

View on ClinicalTrials.gov: NCT03864536 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jul 2024

Primary outcome: Primary: Leisure Activities Questionnaire Activities Sum — 1.45; 4.45; 11.25 score on a scale — p=<0.05

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Cognitive Prescriptions (Behavioral)
Age: Adult, Older Adult · 50+ yrs
Sex: All
Sponsor: University of Alabama at Birmingham
Primary completion: Jan 2022

Outcome Measures

Outcome	Result	p-value
PRIMARY Leisure Activities Questionnaire Activities Sum	1.45; 4.45; 11.25	<0.05 sig
SECONDARY Dementia Knowledge	10; 27; 19	<0.05 sig

Summary

The goal of this R21 study is to explore the feasibility and preliminary efficacy of individualized cognitive prescriptions (CogRxs) in improving engagement in healthy behaviors and other outcomes in middle-aged AAs and to gain feedback on future implementation of the program.

Eligibility Criteria

Inclusions:

Must be African American
Must be age 50 to 65
Must have a working cell phone with unlimited texting
Must be ambulatory

Exclusions:

No neurological (including dementia diagnosis) or severe psychiatric (e.g., schizophrenia or bipolar disorder) disorders
No insomnia
Telephone Interview for Cognitive Status (TICS) score ≤20

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03864536). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.